๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Irbesartan reduces cardiovascular risk in hypertensive diabetic and non-diabetic subjects independent of BMI

โœ Scribed by Fernando De Alvaro; Jesus Honorato; Carlos Calvo; Claudia Filozof; Olga Velasco; Miguel A. Sanchez; Inma Parrondo


Book ID
116209017
Publisher
Nature Publishing Group
Year
2005
Tongue
English
Weight
106 KB
Volume
18
Category
Article
ISSN
0895-7061

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Circulating lipids and cardiovascular ri
โœ Shelgikar, K.M.; Naik, S.S.; Khopkar, M.; Bhat, D.S.; Raut, K.N.; Joglekar, C.V. ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 99 KB ๐Ÿ‘ 1 views

Circulating concentrations of total cholesterol, triglycerides, non-esterified fatty acids (NEFA), glycerol, and 3-hydroxybutyrate (3-HB) were measured in 133 subjects with normal glucose tolerance (NGT), 78 with impaired-glucose-tolerance (IGT) and 189 noninsulin dependent (Type 2) diabetic (NIDDM)

Arterial hypertension and glycemia in no
โœ A. Kroke; A.D. Liese; U. Keil; H. Boeing ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 121 KB ๐Ÿ‘ 1 views

## Background: A possible association of glycemia with arterial hypertension has been suggested by the frequent co-occurrence of impaired glucose tolerance or type 2 diabetes mellitus with arterial hypertension. the objective was to examine the relationship of glycated hemoglobin (hba1c) concentrat